Stock comparison

LLYvsV

Eli Lilly and CovsVisa Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

LLY

Eli Lilly and Co

$917.65

-12.96%

Pharmaceuticals$884.0BNYSE

Visa Inc

$308.88

-10.73%

Financial Services$584.8BNYSE

60-day price, rebased to 100

LLY -11.52% · V -6.10%

Round-by-round

LLY 3·V 2· 1tie

EdgeV

Valuation upside

-70.70% vs -51.50% to DCF fair value

EdgeLLY

Balance-sheet strength

Altman Z 8.14 vs 7.21

EdgeLLY

Fundamental quality

Piotroski 8.00 vs 3.00 (of 9)

Tie

Growth + margins

Rule-of-40 53.90 vs 53.90

EdgeV

60-day momentum

-11.52% vs -6.10% price return

EdgeLLY

Market-cap liquidity

$884.0B vs $584.8B

Verdict

Across6categories,LLYtakes the edge with3wins to2 (and 1 tie). Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onLLYorV

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.